Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Substitution Therapy in Central Diabetes Insipidus
NCT06036004Phase 2Recruiting
- Sponsor
- University Hospital Basel
- Start
- Jan 2024
- Primary completion
- Oct 2026
- Countries
- 3
01
Overview
A Phase 2 trial of oxytocin nasal spray in central diabetes insipidus (CDI), sponsored by University Hospital Basel. Started Jan 2024; status: recruiting.
02
Drugs
oxytocin nasal spray
03
Conditions
central diabetes insipidus (CDI)
Beyond the preview
Go deeper on NCT06036004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06036004.